# FDA Inspection 1120581 - CSL Plasma Inc. - February 05, 2020

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/afa5ca83-6abf-4c8d-b065-2599aff5ef72
Source feed: FDA_Inspections

> FDA Inspection 1120581 for CSL Plasma Inc. on February 05, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1120581
- Company Name: CSL Plasma Inc.
- Inspection Date: 2020-02-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1005990 - 2017-03-31](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/f0357311-fdc9-4961-ab98-8f311aada474)
- [FDA Inspection 901819 - 2014-10-31](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/506b7fd6-fe09-42a6-96fe-b602dbc31cb7)
- [FDA Inspection 800844 - 2012-09-24](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/08f37aef-786b-4f0a-8670-759deacad0eb)
- [FDA Inspection 676987 - 2010-08-19](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/e402723e-76f1-42f4-9dc3-ab3946d3e504)

Company: https://www.keypedia.com/companies/csl-plasma-inc/f2a463c0-909b-4a4d-bf6b-ddbbd9a17003

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d